Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Head and Neck Neoplasms × Decitabine × Clear all

Phase

Status

Terminated 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 18 Myelodysplastic Syndromes 7 Leukemia 6 Leukemia, Myelomonocytic, Chronic 5 Recurrence 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Myeloproliferative Disorders 3 Melanoma 3 Congenital Abnormalities 3 Neoplasms 2 Neoplasm Metastasis 2 Leukemia, Myelomonocytic, Acute 2 Leukemia, Monocytic, Acute 2 Leukemia, Megakaryoblastic, Acute 2 Leukemia, Erythroblastic, Acute 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Unspecified Adult Solid Tumor, Protocol Specific 1 Triple Negative Breast Neoplasms 1 Thrombocythemia, Essential 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Pancreatic Adenocarcinoma Metastatic 1 Ovarian Neoplasms 1 Neuroectodermal Tumors, Primitive 1 Mesothelioma, Malignant 1 Medulloblastoma 1

Interventions

Cisplatin 25 Radiotherapy 21 pembrolizumab 20 Cetuximab 17 Fluorouracil 11 Docetaxel 11 Radiotherapy, Intensity-Modulated 10 Paclitaxel 8 Radiation 7 Everolimus 7 Nivolumab 6 Carboplatin 6 Gemcitabine 5 Surgical Procedures, Operative 4 Magnetic Resonance Spectroscopy 4 Amifostine 4 Radiosurgery 3 Pemetrexed 3 Oxaliplatin 3 Gefitinib 3 Filgrastim 3 Capecitabine 3 Bleomycin 3 Biopsy 3 spartalizumab 2 pegfilgrastim 2 niraparib 2 bempegaldesleukin 2 atezolizumab 2 advexin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04252248 2021-10-06

DERANO

University Hospital Heidelberg

Phase 1 Terminated

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡